| Literature DB >> 30532222 |
Shirani M K Widana Gamage1, Dorith Rotenberg2, Derek J Schneweis3, Chi-Wei Tsai4, Ralf G Dietzgen1.
Abstract
Thrips palmi is a widely distributed major agricultural pest in the tropics and subtropics, causing significant losses in cucurbit and solanaceous crops through feeding damage and transmission of tospoviruses. Thrips palmi is a vector of capsicum chlorosis virus (CaCV) in Australia. The present understanding of transmission biology and potential effects of CaCV on T. palmi is limited. To gain insights into molecular responses to CaCV infection, we performed RNA-Seq to identify thrips transcripts that are differentially-abundant during virus infection of adults. De-novo assembly of the transcriptome generated from whole bodies of T. palmi adults generated 166,445 contigs, of which ~24% contained a predicted open reading frame. We identified 1,389 differentially-expressed (DE) transcripts, with comparable numbers up- (708) and down-regulated (681) in virus-exposed thrips compared to non-exposed thrips. Approximately 59% of these DE transcripts had significant matches to NCBI non-redundant proteins (Blastx) and Blast2GO identified provisional functional categories among the up-regulated transcripts in virus-exposed thrips including innate immune response-related genes, salivary gland and/or gut-associated genes and vitellogenin genes. The majority of the immune-related proteins are known to serve functions in lysosome activity and melanisation in insects. Most of the up-regulated oral and extra-oral digestion-associated genes appear to be involved in digestion of proteins, lipids and plant cell wall components which may indirectly enhance the likelihood or frequency of virus transmission or may be involved in the regulation of host defence responses. Most of the down-regulated transcripts fell into the gene ontology functional category of 'structural constituent of cuticle'. Comparison to DE genes responsive to tomato spotted wilt virus in Frankliniella occidentalis indicates conservation of some thrips molecular responses to infection by different tospoviruses. This study assembled the first transcriptome in the genus Thrips and provides important data to broaden our understanding of networks of molecular interactions between thrips and tospoviruses.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30532222 PMCID: PMC6286046 DOI: 10.1371/journal.pone.0208538
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary statistics for T. palmi de-novo assembled transcriptome.
| Assembly feature | Statistic |
|---|---|
| Total assembled contigs | 166,445 |
| Total assembled bases | 152,899,637 |
| Mean contig length | 919 bp |
| N 50 contig length | 2,114 bp |
| No. contigs with predicted ORFs | 39,449 |
| No. contigs ≥ 400 bp with predicted ORFs | 32,262 |
| Blastx matches ( | 22,582 |
| B2GO annotations | 10,407 |
Fig 1Comparison of normalized read counts (FPKM) between CaCV-exposed and non-exposed adults of Thrips palmi.
Each point represents one transcript with log2 fold change > 1 in relative abundance between the two treatments and a q-value < 0.01. rp = Pearson’s correlation coefficient.
Fig 2Number and functional categories of gene ontology terms assigned for up-regulated and down-regulated transcripts of CaCV-exposed Thips palmi at level 2.
List of significantly up-regulated DE (q < 0.01, log2-FC > 1.0, FPKM >10) transcripts categorized based on Blastx descriptions and GO terms that are predicted to be associated with innate immunity, salivary glands and fitness and fecundity in CaCV-exposed and non-exposed Thrips palmi transcriptome.
| Putative pathway | Blastx description | FPKM | FPKM (virus-exposed) | log2- FC | GO term | Putative function |
|---|---|---|---|---|---|---|
| Cathepsin B (10) | 40.9–501.4 | 166–1188.8 | 1.0–2.0 | Viral entry into host cells, Proteolysis, Endopeptidase activity, Lysosome | Innate immunity [ | |
| Lipase 1 (4) | 3.2–33.6 | 20.7–82.5 | 1.3–2.7 | Hydrolase activity, Lipid metabolic process, Membrane | Antiviral [ | |
| Lysosomal aspartic protease (3) | 316.5–360.9 | 934.4–1127.5 | 1.6 | Proteolysis, Lysosome | Innate immunity [ | |
| Lysozyme C (2) | 37.2–341.7 | 115–784.3 | 1.2 | Lysozyme activity | Innate immunity [ | |
| Acid-phosphatase-1 | 8.4 | 20.8 | 1.3 | Acid phosphatase activity | Antimicrobial [ | |
| Beta mannosidase | 4.3 | 10.6 | 1.3 | CHO metabolic process | Innate immunity [ | |
| Phenoloxidase 2 (6) | 2.3–42.5 | 10.0–91.0 | 1.0–2.3 | Melatonin encapsulation of foreign target, L-DOPA monooxygenase activity, Defence, Oxidation-reduction | Innate immunity [ | |
| Phenoloxidase subunit A3 | 16.4 | 51.8 | 1.7 | Oxidation-reduction | Innate immunity [ | |
| Serine protease ester-like | 14.9 | 47.8 | 1.7 | Proteolysis, Melanisation defence response | Innate immunity [ | |
| Glucose dehydrogenase [quinone] (9) | 5.2–77.8 | 12.8–193.4 | 1.0–1.6 | Oxidation-reduction process | Innate immunity [ | |
| Poly(U)-specific endoribonuclease homologue (3) | 93–11.0 | 31.7–38.2 | 1.8 | Hydrolase activity | Innate immunity [ | |
| Laccase-5 isoform X1 | 19.4 | 61.5 | 1.7 | Oxidation-reduction process | Innate immunity [ | |
| Troponin isoform 1 like (2) | 13.7–65.8 | 28.4–208.1 | 1.0–1.6 | Protein binding, Calcium binding | Innate immunity [ | |
| Serine protease 13 | 143.0 | 354.3 | 1.3 | Proteolysis, Serine-type peptidase activity | Innate immunity [ | |
| Carboxypeptidase B like (3) | 4.5–146.3 | 27.8–328.0 | 1.3–3.3 | Proteolysis, Metallo-carboxypeptidase | Innate immunity [ | |
| Coagulation factor ix | 11.6 | 31.0 | 1.4 | Zymogen activation, Extracellular exosome | Innate immunity [ | |
| Limulus clotting factor C like | 11.1 | 31.6 | 1.5 | Protein binding | Innate immunity [ | |
| Defensin 2 | 10.4 | 47.2 | 2.2 | Defence response | Innate immunity [ | |
| Gram-negative bacteria-binding 3-like | 132.8 | 469.8 | 1.8 | CHO binding | Innate immunity [ | |
| Serine protease 44 | 5.9 | 18.9 | 1.7 | Proteolysis, Serine-type peptidase activity | Innate immunity [ | |
| 70 kDa heat shock partial | 20.2 | 54.7 | 1.4 | ATP binding | Antiviral [ | |
| Heat shock 70 a1 partial | 54.7 | 113.0 | 1.0 | ATP binding, Extracellular exosome | Antiviral [ | |
| Heat shock cognate 71 | 31.7 | 90.6 | 1.1 | ATP binding | Antiviral [ | |
| Serine protease (4) | 15.3–95.8 | 31.4–218.7 | 1.0–1.7 | Proteolysis, Serine-type peptidase activity | Innate immunity [ | |
| Serine protease 12 -like (3) | 4.2–37.8 | 13.0–109.9 | 1.6 | Proteolysis, Serine-type peptidase activity | Innate immunity [ | |
| Serine protease 9-like (5) | 8.2–38.6 | 21.0–92.9 | 1.3–1.5 | Proteolysis, Serine-type peptidase activity | Innate immunity [ | |
| Trypsin-like serine protease (3) | 2.6–26.2 | 12.8–73.5 | 1.5–2.3 | Proteolysis, Serine-type peptidase activity | Innate immunity [ | |
| Trypsin | 7.6–32.0 | 16.1–85.0 | 1.0–1.5 | Proteolysis, Serine-type peptidase activity | Innate immunity [ | |
| Apolipo D-like (2) | 12.8–29.1 | 43.6–78.3 | 1.4–1.8 | Pigment binding | Innate immunity [ | |
| Chitin binding peritrophin-A domain containing (2) | 33.0–48.3 | 110.0–211.8 | 1.7–2.1 | Chitin metabolic process | Innate immunity [ | |
| Chymotrypsin protease (4) | 8.7–28.5 | 22.1–89.1 | 1.3–1.6 | Proteolysis | Innate immunity [ | |
| Cytochrome P450 4C1 (2) | 3.5–10.9 | 15.7–31.7 | 1.5–2.1 | Oxidation-reduction process | Immunity [ | |
| Cytochrome P450 6k1-like | 313.5 | 634.1 | 1.0 | Oxidation-reduction process | Immunity [ | |
| Extracellular serine threonine kinase FAM20C | 44.2 | 135.8 | 1.6 | Protein phosphorylation | Immunity [ | |
| Esterase FE4-like | 6.0 | 16.7 | 1.5 | Hydrolase activity | Innate immunity [ | |
| Facilitated trehalose transporter Tret1-like | 9.7 | 19.6 | 1.0 | Transmembrane transport | Immunity [ | |
| Elicitin 6 partial | 12.2 | 33.0 | 1.4 | Defence response, Chitin binding | Defence response in plants [ | |
| Pathogenesis-related protein 5-like | 5.8 | 15.8 | 1.4 | Systemic acquired resistance, Response to virus, apoplastic | Defence response in plants [ | |
| Lipase 3 (15) | 2.5–71.8 | 12.3–347.4 | 1.0–2.3 | Lipid metabolic process, Hydrolase activity | General digestion [ | |
| Seine protease (9) | 5.9–95.8 | 18.8–218.2 | 1.0–1.7 | proteolysis | ||
| Trypsin-like serine protease (3) | 2.6–26.2 | 12.8–73.4 | 1.5–2.3 | Proteolysis, Serine-type peptidase activity | ||
| Carboxypeptidase (3) | 4.5–146.4 | 27.8–328.0 | 1.3–3.3 | Proteolysis | ||
| Pectin lyase (4) | 32.4–216.8 | 68.1–507.0 | 1.0–1.5 | Polysaccharide catabolic process | Digestion of plant cell wall [ | |
| β-glucosidase | 2.3 | 12.0 | 2.3 | Carbohydrate metabolic process | ||
| Endoglucanase (4) | 66.5–152.1 | 166.7–339.2 | 1.2–1.3 | Fructose, Sucrose metabolic process, Cellulase activity | ||
| α-amylase A-like | 69.0 | 186.8 | 1.4 | Sucrose metabolic process, Extracellular exosome | Sugar metabolism [ | |
| Angiotensin-converting enzyme-like | 8.4 | 17.0 | 1.0 | Proteolysis | Detoxification and inhibition of plant defence [ | |
| Phosphoribosyl formylglycinamidine synthase | 24.7 | 56.2 | 1.2 | Advantageous for infecting virus [ | ||
| Uridine phosphorylase 1 isoform X1 | 3.1 | 10.9 | 1.8 | Nucleoside metabolic process | Salivary gland [ | |
| Pyridoxal phosphate phosphatase | 8.3 | 46.7 | 2.5 | Dephosphorylation, Hydrolase activity | Salivary gland expressed gene [ | |
| Vitellogenin (54) | 3.1–2446.1 | 11–7446 | 1.0–2.6 | Lipid transport | Reproduction [ | |
| LPXTG-domain-containing cell wall anchor partial | 28.0 | 77.7 | 1.5 | Phosphorylation | Cell surface adhesion [ | |
FC = fold change of virus-exposed treatment relative to non-virus control treatment.
List of significantly down-regulated DE (q < 0.01, log2-FC > 1.0, FPKM >10) transcripts in CaCV-exposed and non-exposed Thrips palmi transcriptome.
| Blastx description | FPKM | FPKM (virus-exposed) | log2- FC | GO term |
|---|---|---|---|---|
| Larval cuticle A2B-like (3) | 117.1–220.8 | 0.3–1.8 | 9.3–8.0 | Structural constituent of cuticle |
| Serine protease inhibitor 3 4 isoform X1 | 44.2 | 0.2 | 7.9 | Extracellular space |
| Pupal cuticle C1B-like (2) | 29.4–100.6 | 0.1–0.6 | 7.4–7.6 | Structural constituent of cuticle |
| Endocuticle structural glyco bd-8-like | 53.6 | 0.4 | 7.1 | Structural constituent of cuticle |
| Alpha-tocopherol transfer -like | 28.2 | 0.2 | 7.0 | Transport |
| Collagen alpha-1(III) chain-like | 47.2 | 0.5 | 6.5 | Chitin binding, Extracellular region |
| Uncharacterized protein LOC106678716 | 29.6 | 0.3 | 6.4 | Integral component of membrane |
| Apolipo D-like | 85.8 | 1.0 | 6.4 | Pigment binding |
| Endocuticle structural glyco bd-4-like (2) | 29.8–203 | 0.4–2.8 | 6.2–6.3 | Structural constituent of cuticle |
| Uncharacterized protein LOC103510819 | 24.2 | 0.3 | 6.1 | Integral component of membrane |
| Trypsin | 24.2 | 0.4 | 6.0 | Proteolysis; serine-type endopeptidase activity |
| Serine ase stubble | 72.8 | 1.1 | 6.0 | GTPase activity, Proteolysis, Serine-type endopeptidase activity |
| Probable chitinase- 3 | 19.4 | 0.3 | 6.0 | Chitinase activity, Extracellular region |
| Fibroin heavy chain | 32.7 | 0.5 | 5.9 | Structural constituent of cuticle |
| Cuticle 7 | 49.6 | 0.8 | 5.9 | Structural constituent of cuticle |
| Glycine-rich cell wall structural -like | 37.4 | 0.7 | 5.8 | Anatomical structure development |
| Cuticular analogous to peritrophins 1-G | 12.5 | 0.2 | 5.7 | Chitin binding, Chitin metabolic process, Extracellular region |
| Cytochrome P450 4g15 | 26.1 | 0.5 | 5.7 | Iron ion binding, Oxidation-reduction process |
| Serine ase stubble isoform X2 | 16.7 | 0.4 | 5.5 | GTP binding, Serine-type endopeptidase activity |
| Location of vulva defective 1 isoform X2 | 12.7 | 0.3 | 5.5 | Membrane, Integral component of membrane |
| COPII coat assembly partial | 87.2 | 1.9 | 5.5 | Neuropeptide signaling pathway |
| Sal 1 | 20.9 | 0.5 | 5.5 | Nucleic acid binding |
| Glucose dehydrogenase | 14.5 | 0.3 | 5.4 | Oxidation-reduction process |
| Proclotting enzyme-like | 14.8 | 0.3 | 5.4 | Proteolysis, Serine-type endopeptidase activity |
| Larval cuticle A3A-like | 24.2 | 0.7 | 5.2 | Structural constituent of cuticle |
| Glycine-rich cell wall structural -like | 12.9 | 0.3 | 5.2 | Chitin-based cuticle development, Structural constituent of chitin-based cuticle |
| Endocuticle structural glyco bd- partial | 168.6 | 4.8 | 5.1 | Structural constituent of cuticle, Extracellular space |
| Osiris 14 | 15.2 | 0.4 | 5.1 | Integral component of membrane |
| Cuticular precursor | 24.1 | 0.7 | 5.1 | Structural constituent of cuticle, Nucleic acid binding |
| Endocuticle structural glyco bd-2-like | 33.4 | 1.0 | 5.0 | Structural constituent of cuticle, Extracellular space |
FC = fold change of virus-exposed treatment relative to non-virus control treatment.
Fig 3Validation of RNA-Seq gene expression by qPCR.
FPKM values obtained by RNA-Seq analysis and relative expression levels obtained by qPCR for six selected genes in CaCV-exposed and non-exposed Thrips palmi are shown. Values were multiplied by a factor of 1000. Error bars represent the standard error for three biological replicates.
List of conserved up-regulated transcript sequences in two adult-stage thrips—tospovirus interactions.
| Tp transcript annotation | Focc—TSWV transcript code | Tp—CaCV transcript code | Log2 FC Focc | Log2 FC Tp | % sequence identity | Sequence coverage |
|---|---|---|---|---|---|---|
| DNase I | FOCC007280-RA | TP.8153.1 | + 2.62 | + 1.31 | 86 | 1186 nt |
| Uncharacterized protein LOC106129042 | TCONS_00032732 | TP.1784.1 | + 2.06 | + 2.47 | 81 | 194 aa |
| Endoglucanase | FOCC015899-RA | TP.19931.1, TP21769.1, TP.21770.1, TP.21771.1 | + 1.95 | + 1.2 to + 1.3 | 80 | 115 aa |
| Carbonic anhydrase | CUFF.8568.2 | TP.33694.1 | + 2.88 | + 2.08 | 80 | 92 aa |
| Uncharacterized protein LOC105690123 | CUFF.8228.1 | >10 Isoforms | + 2.58 | up | 62 | < 200 aa |
| Hexamerin | FOCC009367-RA | TP.20198.1 | + 4.20 | + 1.81 | 45 | 33 aa |
| Hemocyanin subunit type 1 precursor | FOCC002013-RA | TP.20202.1 | + 13.31 | + 1.75 | 38 | 50 aa |
| Hexamerin, arylphorin subunit alpha | FOCC012829-RA | TP.25095.1 | + 8.87 | + 1.1 | 38 | 45 aa |
Focc = Frankliniella occidentalis; TSWV = tomato spotted wilt virus; Tp = Thrips palmi; CaCV = capsicum chlorosis virus; nt = nucleotides; aa = amino acids. FC = fold change of virus-exposed treatment in relative to non-virus control treatment.
# Annotated as phenol oxidase 2-like